Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • apolanow
    Junior Member
    • May 2009
    • 1

    #1

    2nd round miseq

    Hi
    I am wondering if you can help me please.
    My boss has recently returned from a metabarcoding conference in Europe and noted that labs are now using dual indexes in the first round of PCR and then sending their library away to have the second round ligated on for miseq.
    We are going to try and do this in house. We are thinking of dual barcoding the first round of PCR with 6bp indexes. We would then like to either
    a. Use a prep that ligates Illumina adapters onto the pool of amplicons
    b. Do the whole reaction in one tube. Ie a 2-phase PCR addition. Some labs have got this to work, apparently. Early round PCR is at a low temp for the marker, then a second phase adds the tags and P5+P7.

    We currently do a 2-step PCR addition of MIDs+P5 and P7 sequences. We use the Illumina protocol for 16S rDNA bacterial as a guide. It has problems with contamination control and 2-step PCR is very fidly, prone to pipetting errors and time consuming.

    Any help with this would be appreciated.

    Thanks
    Andrea
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    The approach depends on your target region and the analysis type.

    If the aim is to analyse and compare samples quantitatively then barcoding primers might affect the result by preferential amplification of some targets in different samples because the barcode overhang will be different in samples. One tube two step PCR would have more artefacts and possibly low yield. For this approach target size should be long enough to allow proper clean up of products from primers interactions.

    Two step PCR will be labour intensive but results will be reproducible and quantitatively comparable.

    If you are looking for presence-absence either of them that suits your lab set up should be fine.

    Comment

    • martinjf
      Member
      • Dec 2009
      • 14

      #3
      totally agree with the first answer.
      solution a works fine but is costly and time consuming. We did it for years and moved to the 2-step pcr that is bot hvery flexible and quite cheap. The solution b works fine for particular systems (as v3-v4 16S regions for example) but needs particular fine tuning for each new marker.
      I was probably at the same meeting (Upsala) and most presentations were using a 2-steps PCR approach.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 10:13 AM
      0 responses
      13 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      19 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      18 views
      0 reactions
      Last Post SEQadmin2  
      Working...